Free cash flow · 2012–2023

Travere Therapeutics free cash flow

−$281M−$94.2M · FY2023

Travere Therapeutics (TVTX) reported −$281M in free cash flow for fiscal 2023, −$94.2M from the year before.

−$2.8M2012−$17.7M2013−$46.5M2014−$1.4M2015−$4.9M2016$6.5M2017−$25.7M2018−$58.4M2019−$49.5M2020−$19.9M2021−$186M2022−$281M2023
Travere Therapeutics — Free cash flow, 2012–2023
Fiscal yearFree cash flowChangeFiling
FY2023−$281M−$94.2MDerived
FY2022−$186M−$167MDerived
FY2021−$19.9M+$29.6MDerived
FY2020−$49.5M+$8.9MDerived
FY2019−$58.4M−$32.7MDerived
FY2018−$25.7M−$32.2MDerived
FY2017$6.5M+$11.4MDerived
FY2016−$4.9M−$3.5MDerived
FY2015−$1.4M+$45.1MDerived
FY2014−$46.5M−$28.8MDerived
FY2013−$17.7M−$14.9MDerived
FY2012−$2.8M—Derived

Free cash flow — Free cash flow is operating cash flow minus capital expenditure: what is left once the company has paid to maintain and expand its asset base. We calculate it from two lines in the same filing, and a company is only ranked here if it reported both.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Calculated from two reported figures, so it has no single filing of its own.

Free cash flow at companies of similar size

Full ranking by free cash flow →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Travere Therapeutics free cash flow |url=https://companiesranked.com/en/company/travere-therapeutics/free-cash-flow |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Travere Therapeutics free cash flow. CompaniesRanked. https://companiesranked.com/en/company/travere-therapeutics/free-cash-flow

BibTeX

@misc{companiesranked-en-company-travere-therapeutics-free-cash-flow-2026,
  author       = {{CompaniesRanked}},
  title        = {{Travere Therapeutics free cash flow}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/travere-therapeutics/free-cash-flow}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Travere Therapeutics overview